.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Argus Health
Johnson and Johnson
Cerilliant
Fuji
Mallinckrodt
Chinese Patent Office
McKesson
McKinsey

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022411

« Back to Dashboard
NDA 022411 describes OLEPTRO, which is a drug marketed by Angelini Pharma and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the OLEPTRO profile page.

The generic ingredient in OLEPTRO is trazodone hydrochloride. There are thirteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

Summary for NDA: 022411

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 2, 2010TE:RLD:Yes
Patent:6,607,748Patent Expiration:Jun 29, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:8,133,893Patent Expiration:Mar 13, 2029Product Flag?YSubstance Flag?YDelist Request?
Patent:7,829,120Patent Expiration:Mar 27, 2027Product Flag?YSubstance Flag?Delist Request?
Patented Use:METHOD OF TREATING DEPRESSION


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Accenture
Johnson and Johnson
McKinsey
Citi
US Department of Justice
Farmers Insurance
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot